UK markets closed

BioNTech SE (0A3M.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
88.30-3.07 (-3.37%)
At close: 12:10PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 22.34B
Enterprise value 4.82B
Trailing P/E 22.56
Forward P/E 7.07
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.49
Price/book (mrq)1.03
Enterprise value/revenue 1.26
Enterprise value/EBITDA 4.43

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-13.95%
S&P500 52-week change 322.38%
52-week high 3125.74
52-week low 385.38
50-day moving average 390.65
200-day moving average 3100.25

Share statistics

Avg vol (3-month) 33.84k
Avg vol (10-day) 32.62k
Shares outstanding 5239.77M
Implied shares outstanding 6275.06M
Float 886.11M
% held by insiders 165.11%
% held by institutions 117.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 406 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 47.64%
Operating margin (ttm)63.95%

Management effectiveness

Return on assets (ttm)16.92%
Return on equity (ttm)23.82%

Income statement

Revenue (ttm)9.18B
Revenue per share (ttm)37.94
Quarterly revenue growth (yoy)-94.80%
Gross profit (ttm)N/A
EBITDA 5.94B
Net income avi to common (ttm)4.38B
Diluted EPS (ttm)18.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.56B
Total cash per share (mrq)64.88
Total debt (mrq)205.7M
Total debt/equity (mrq)1.03%
Current ratio (mrq)10.56
Book value per share (mrq)83.02

Cash flow statement

Operating cash flow (ttm)9.32B
Levered free cash flow (ttm)8.41B